Site icon OncologyTube

Outcomes Of The KEYNOTE 426 Phase III Study In mRCC

Rana McKay, MD, Medical Oncologist, Assistant Professor of Medicine, University of California, San Diego, Discusses Outcomes Of The KEYNOTE 426 Phase III Study In mRCC. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019.

http://obroncology.com

Exit mobile version